The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

Journal: Current Neuropharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 256-268
Author(s): Pawel Kawalec,Alicja Mikrut,Natalia Wisniewska,Andrzej Pilc

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

Journal: Reviews on Recent Clinical Trials
Volume: 5 Issue: 3 Year: 2010 Page: 179-188
Author(s): James J. Marriott, Paul W. OConnor

Aligned Expression of IFI16 and STING Genes in RRMS Patients’ Blood

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 6 Year: 2020 Page: 878-886
Author(s): Sobhan Helbi,Behnam Ravanbakhsh,Mohammad Karimi,Wesam Kooti,Nahid Jivad

An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4475-4484
Author(s): Brigitte K. Paap,Alexander Hundeshagen,Michael Hecker,Uwe K. Zettl

An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 6 Year: 2015 Page: 804-810
Author(s): Rodica Balasa,Smaranda Maier,Septimiu Voidazan,Adina Hutanu,Zoltan Bajko,Anca Motataianu

Journal: Current Neuropharmacology
Volume: 8 Issue: 3 Year: 2010 Page: 305-315
Author(s): Dirk Fitzner, Mikael Simons

Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 9 Year: 2017 Page: 1018-1026
Author(s): Rodica Ioana Balasa,Mihaela Simu,Septimiu Voidazan,Laura Iulia Barcutean,Zoltan Bajko,Adina Hutanu,Iunius Simu,Smaranda Maier

Immune Therapy of Multiple Sclerosis - Future Strategies

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4489-4497
Author(s): Sven G. Meuth,Kerstin Gobel,Heinz Wiendl

Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 7 Year: 2010 Page: 640-650
Author(s): Corinna Trebst, Elke Voß, Thomas Skripuletz, Martin Stangel

From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis

Journal: Current Neuropharmacology
Volume: 15 Issue: 6 Year: 2017 Page: 874-891
Author(s): Lilian Aly,Bernhard Hemmer,Thomas Korn